S100PBP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.400400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.608400E-01
Normal-vs-Stage2
3.431800E-01
Normal-vs-Stage3
2.389800E-01
Normal-vs-Stage4
3.889000E-01
Stage1-vs-Stage2
8.853000E-01
Stage1-vs-Stage3
1.135150E-01
Stage1-vs-Stage4
4.531600E-01
Stage2-vs-Stage3
1.635780E-01
Stage2-vs-Stage4
3.136400E-01
Stage3-vs-Stage4
1.168440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.411800E-01
Normal-vs-AfricanAmerican
1.970570E-01
Normal-vs-Asian
2.819800E-01
Caucasian-vs-AfricanAmerican
5.840200E-01
Caucasian-vs-Asian
2.442400E-01
AfricanAmerican-vs-Asian
2.105800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.306800E-01
Normal-vs-Female
3.521200E-01
Male-vs-Female
4.717800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.606200E-01
Normal-vs-Age(41-60Yrs)
4.167200E-01
Normal-vs-Age(61-80Yrs)
3.148000E-01
Normal-vs-Age(81-100Yrs)
2.695200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.962200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.177000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.436000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.464900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.623700E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.339200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.922400E-01
Normal-vs-Daily Drinker
2.894800E-01
Normal-vs-Weekly Drinker
3.128800E-01
Normal-vs-Occasional Drinker
3.665400E-01
Normal-vs-Social Drinker
1.230250E-01
Non Drinker-vs-Daily Drinker
9.428000E-01
Non Drinker-vs-Weekly Drinker
7.357400E-01
Non Drinker-vs-Occasional Drinker
1.812210E-01
Non Drinker-vs-Social Drinker
5.638200E-02
Daily Drinker-vs-Weekly Drinker
6.926800E-01
Daily Drinker-vs-Occasional Drinker
1.687170E-01
Daily Drinker-vs-Social Drinker
5.889800E-02
Weekly Drinker-vs-Occasional Drinker
4.035000E-01
Weekly Drinker-vs-Social Drinker
1.835970E-01
Occasional Drinker-vs-Social Drinker
4.713000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.226000E-01
Normal-vs-Grade 2
6.768400E-01
Normal-vs-Grade 3
2.516400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.249030E-01
Grade 1-vs-Grade 3
2.176400E-01
Grade 1-vs-Grade 4
5.226000E-01
Grade 2-vs-Grade 3
9.874400E-01
Grade 2-vs-Grade 4
6.768400E-01
Grade 3-vs-Grade 4
2.516400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.168000E-01
Normal-vs-NonDiabetic
3.258600E-01
Diabetic-vs-NonDiabetic
7.457800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.975200E-01
Normal-vs-NoPancreatitis
3.216800E-01
Pancreatitis-vs-NoPancreatitis
2.314000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.469200E-01
Normal-vs-N1
3.422400E-01
N0-vs-N1
9.356600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.213600E-01
Normal-vs-TP53-NonMutant
3.205800E-01
TP53-Mutant-vs-TP53-NonMutant
9.826800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
